Morgan Stanley’s SCYNEXIS SCYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.8K | Sell |
3,109
-2,653
| -46% | -$16.4K | ﹤0.01% | 6672 |
|
|
2025
Q4 | $29.1K | Buy |
5,762
+3,799
| +194% | +$20.7K | ﹤0.01% | 6582 |
|
|
2025
Q3 | $12.1K | Hold |
1,963
| – | – | ﹤0.01% | 6847 |
|
|
2025
Q2 | $10.6K | Hold |
1,963
| – | – | ﹤0.01% | 6847 |
|
|
2025
Q1 | $14.9K | Hold |
1,963
| – | – | ﹤0.01% | 6669 |
|
|
2024
Q4 | $19K | Hold |
1,963
| – | – | ﹤0.01% | 6585 |
|
|
2024
Q3 | $23.4K | Sell |
1,963
-514
| -21% | -$7.27K | ﹤0.01% | 6454 |
|
|
2024
Q2 | $39.6K | Sell |
2,477
-749
| -23% | -$11.6K | ﹤0.01% | 6241 |
|
|
2024
Q1 | $37.9K | Sell |
3,226
-699
| -18% | -$9.88K | ﹤0.01% | 6317 |
|
|
2023
Q4 | $70K | Buy |
3,925
+2,350
| +149% | +$34.5K | ﹤0.01% | 6278 |
|
|
2023
Q3 | $28.7K | Hold |
1,575
| – | – | ﹤0.01% | 6369 |
|
|
2023
Q2 | $37.2K | Hold |
1,575
| – | – | ﹤0.01% | 6328 |
|
|
2023
Q1 | $37.8K | Sell |
1,575
-624
| -28% | -$8.29K | ﹤0.01% | 6384 |
|
|
2022
Q4 | $27.4K | Buy |
2,199
+436
| +25% | +$7.71K | ﹤0.01% | 6548 |
|
|
2022
Q3 | $34K | Buy |
1,763
+100
| +6% | +$1.96K | ﹤0.01% | 6573 |
|
|
2022
Q2 | $25K | Buy |
1,663
+1,014
| +156% | +$19.5K | ﹤0.01% | 6902 |
|
|
2022
Q1 | $20K | Sell |
649
-977
| -60% | -$37.4K | ﹤0.01% | 7156 |
|
|
2021
Q4 | $79K | Sell |
1,626
-4,860
| -75% | -$239K | ﹤0.01% | 6574 |
|
|
2021
Q3 | $275K | Buy |
6,486
+2,670
| +70% | +$140K | ﹤0.01% | 5831 |
|
|
2021
Q2 | $225K | Buy |
3,816
+3,300
| +640% | +$208K | ﹤0.01% | 5952 |
|
|
2021
Q1 | $33K | Buy |
516
+204
| +65% | +$13.4K | ﹤0.01% | 6547 |
|
|
2020
Q4 | $19K | Buy |
312
+187
| +150% | +$8.76K | ﹤0.01% | 6448 |
|
|
2020
Q3 | $4K | Buy |
+125
| New | +$6.12K | ﹤0.01% | 6479 |
|
|
2018
Q4 | – | Sell |
-125
| Closed | -$12K | – | 6713 |
|
|
2018
Q3 | $12K | Buy |
125
+121
| +3,025% | +$14.3K | ﹤0.01% | 6273 |
|
|
2018
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 6735 |
|
|
2018
Q1 | $0 | Buy |
+4
| New | +$552 | ﹤0.01% | 6682 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6596 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6640 |
|
|
2016
Q4 | – | Sell |
-25
| Closed | -$8K | – | 6557 |
|
|
2016
Q3 | $8K | Sell |
25
-92
| -79% | -$19.4K | ﹤0.01% | 6153 |
|
|
2016
Q2 | $20K | Buy |
+117
| New | +$33.1K | ﹤0.01% | 5854 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6690 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6700 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6730 |
|
|
2015
Q1 | – | Sell |
-5
| Closed | -$4.1K | – | 6632 |
|
|
2014
Q4 | $4K | Buy |
+5
| New | +$3.54K | ﹤0.01% | 6370 |
|
|
2014
Q3 | – | Sell |
-25
| Closed | -$16K | – | 6648 |
|
|
2014
Q2 | $16K | Buy |
+25
| New | +$17.5K | ﹤0.01% | 6081 |
|
Other funds holding SCYX
SCM
GPP
APM
HCM
KCM
EAM
VCM
DCM
Morgan Stanley's SCYX Position: Q1 2026 in Review
Morgan Stanley reduced its SCYNEXIS (SCYX) stake by 46% in Q1 2026, selling an estimated $16.4K and leaving 3,109 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6672.
Morgan Stanley first reported a position in SCYX in Q2 2014 and has held it in 30 quarters since. The position peaked at $275K in Q3 2021. 46 funds tracked by Wall St. Rank hold SCYX as of Q1 2026.
- Morgan Stanley held 3,109 shares of SCYNEXIS worth $22.8K as of Q1 2026.
- Morgan Stanley sold 2,653 SCYNEXIS shares in Q1 2026, an estimated $16.4K.
- SCYNEXIS made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6672 holding.
- Morgan Stanley first reported a position in SCYNEXIS in Q2 2014 and has held it in 30 quarters since.
- Morgan Stanley's SCYNEXIS position peaked at $275K in Q3 2021.
- 46 funds tracked by Wall St. Rank held SCYNEXIS as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.